BR112021022501A2 - Composições compreendendo cepas bacterianas - Google Patents

Composições compreendendo cepas bacterianas

Info

Publication number
BR112021022501A2
BR112021022501A2 BR112021022501A BR112021022501A BR112021022501A2 BR 112021022501 A2 BR112021022501 A2 BR 112021022501A2 BR 112021022501 A BR112021022501 A BR 112021022501A BR 112021022501 A BR112021022501 A BR 112021022501A BR 112021022501 A2 BR112021022501 A2 BR 112021022501A2
Authority
BR
Brazil
Prior art keywords
compositions
bacterial strains
treating
relates
present
Prior art date
Application number
BR112021022501A
Other languages
English (en)
Inventor
Alex Stevenson
Sasha Chetal
Original Assignee
4D Pharma Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4D Pharma Res Limited filed Critical 4D Pharma Res Limited
Publication of BR112021022501A2 publication Critical patent/BR112021022501A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/145Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

composições compreendendo cepas bacterianas. a presente invenção refere-se a composições compreendendo uma ou mais cepas bacterianas para tratar ou evitar a hipersensibilidade sensorial.
BR112021022501A 2019-05-10 2020-05-11 Composições compreendendo cepas bacterianas BR112021022501A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19173945 2019-05-10
PCT/EP2020/063084 WO2020229428A1 (en) 2019-05-10 2020-05-11 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
BR112021022501A2 true BR112021022501A2 (pt) 2021-12-28

Family

ID=66668682

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021022501A BR112021022501A2 (pt) 2019-05-10 2020-05-11 Composições compreendendo cepas bacterianas

Country Status (15)

Country Link
US (1) US20210393703A1 (pt)
EP (1) EP3917550B1 (pt)
JP (2) JP7075159B2 (pt)
KR (1) KR20220006517A (pt)
CN (1) CN114072160A (pt)
AU (1) AU2020276670A1 (pt)
BR (1) BR112021022501A2 (pt)
CA (1) CA3138046A1 (pt)
EA (1) EA202193075A1 (pt)
IL (1) IL287747A (pt)
MA (1) MA54871A (pt)
MX (1) MX2021013776A (pt)
SG (1) SG11202112410PA (pt)
TW (1) TW202108153A (pt)
WO (1) WO2020229428A1 (pt)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808689B1 (fr) 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
KR102222273B1 (ko) * 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CN114159476A (zh) 2015-05-14 2022-03-11 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
KR102010207B1 (ko) * 2016-03-04 2019-08-12 4디 파마 피엘씨 세균 균주를 포함하는 조성물
AU2017234120A1 (en) 2016-03-14 2018-09-20 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
TW201821093A (zh) * 2016-07-13 2018-06-16 英商4D製藥有限公司 包含細菌菌株之組合物
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス, インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
EP3710023A1 (en) 2017-11-14 2020-09-23 Evelo Biosciences, Inc. Compositions and methods for treating disease using a blautia strain

Also Published As

Publication number Publication date
MA54871A (fr) 2022-05-11
AU2020276670A1 (en) 2021-12-09
CA3138046A1 (en) 2020-11-19
EA202193075A1 (ru) 2022-02-17
TW202108153A (zh) 2021-03-01
JP2022105169A (ja) 2022-07-12
EP3917550B1 (en) 2024-01-24
SG11202112410PA (en) 2021-12-30
IL287747A (en) 2021-12-01
WO2020229428A1 (en) 2020-11-19
JP7075159B2 (ja) 2022-05-25
KR20220006517A (ko) 2022-01-17
US20210393703A1 (en) 2021-12-23
JP2022525394A (ja) 2022-05-13
MX2021013776A (es) 2021-12-10
CN114072160A (zh) 2022-02-18
EP3917550A1 (en) 2021-12-08

Similar Documents

Publication Publication Date Title
BR112018067689A2 (pt) composições compreendendo cepas bacterianas do gênero blautia para tratar a hipersensibilidade visceral
BR112018075833A2 (pt) composições compreendendo cepas bacterianas
CL2018001358A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001368A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
BR112018004620A2 (pt) moduladores da expressão de kras
MD3804737T2 (ro) Compoziții care conțin tulpini bacteriene
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
CL2017003142A1 (es) Composiciones que comprenden cepas bacterianas
CO2017013446A2 (es) Composiciones que comprenden cepas bacterianas del género bacteroides
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
BR112017000024A2 (pt) composição para tratamento de tecidos que compreende uma nanoemulsão polimérica de aminossiloxano
BR112016028255A2 (pt) agentes imunorreguladores
BR112017028194A2 (pt) moduladores de diaciglicerol aciltransferase 2 (dgat2)
BR112019003577A2 (pt) métodos de tratamento da semente e produtos resultantes
MD3600363T2 (ro) Compoziții cuprinzând tulpini bacteriene
JOP20210158A1 (ar) مُعَدِّلات التعبير الجيني عن hsd17b13
BR112017016520A2 (pt) composições de perfume
BR112017021194A2 (pt) compostos espirocíclicos
MD3630136T2 (ro) Compoziții care cuprind tulpini bacteriene
MD3638271T2 (ro) Compoziții cuprizând tulpini bacteriene
BR112017028493A2 (pt) uso de cepas microbacterianas para a produção de agentes antibacterianos
UY38472A (es) Moduladores de la expresión de foxp3
BR112019027387A8 (pt) Composições imunogênicas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]